• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于6个长链非编码RNA的风险评分系统用于预测结肠癌患者的复发情况。

A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.

作者信息

Yang Haojie, Lin Hong-Cheng, Liu Hua, Gan Dan, Jin Wei, Cui Can, Yan Yixin, Qian Yiming, Han Changpeng, Wang Zhenyi

机构信息

Department of Coloproctology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Coloproctology, The Sixth Affiliated Hospital of Sun Yat-sen University (Gastrointestinal & Anal Hospital of Sun Yat-sen University), Guangzhou, China.

出版信息

Front Oncol. 2020 Feb 6;10:81. doi: 10.3389/fonc.2020.00081. eCollection 2020.

DOI:10.3389/fonc.2020.00081
PMID:32117736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015976/
Abstract

Colon adenocarcinoma (COAD) is a common type of colon cancer, and post-operative recurrence and metastasis may occur in COAD patients. This study is designed to build a risk score system for COAD patients. The Cancer Genome Atlas (TCGA) dataset of COAD (the training set) was downloaded, and GSE17538 and GSE39582 (the validation sets) from Gene Expression Omnibus database were obtained. The differentially expressed RNAs (DERs) were analyzed by limma package. Using survival package, the independent prognosis-associated long non-coding RNAs (lncRNAs) were selected for constructing risk score system. After the independent clinical prognostic factors were screened out using survival package, a nomogram survival model was constructed using rms package. Furthermore, competitive endogenous RNA (ceRNA) regulatory network and enrichment analyses separately were performed using Cytoscape software and DAVID tool. Totally 404 DERs between recurrence and non-recurrence groups were identified. Based on the six independent prognosis-associated lncRNAs (including , and ), the risk score system was constructed. After the independent clinical prognostic factors (Pathologic M, pathologic T, and RS model status) were identified, the nomogram survival model was built. In the ceRNA regulatory network, there were three lncRNAs, four miRNAs, and 77 mRNAs. Additionally, PPAR signaling pathway and hedgehog signaling pathway were enriched for the mRNAs in the ceRNA regulatory network. The risk score system and the nomogram survival model might be used for predicting COAD recurrence. Besides, PPAR signaling pathway and hedgehog signaling pathway might affect the recurrence of COAD patients.

摘要

结肠腺癌(COAD)是结肠癌的常见类型,COAD患者术后可能会发生复发和转移。本研究旨在构建COAD患者的风险评分系统。下载了COAD的癌症基因组图谱(TCGA)数据集(训练集),并从基因表达综合数据库中获取了GSE17538和GSE39582(验证集)。使用limma软件包分析差异表达RNA(DER)。使用生存软件包选择独立的预后相关长链非编码RNA(lncRNA)以构建风险评分系统。使用生存软件包筛选出独立的临床预后因素后,使用rms软件包构建列线图生存模型。此外,分别使用Cytoscape软件和DAVID工具进行竞争性内源性RNA(ceRNA)调控网络分析和富集分析。在复发组和非复发组之间共鉴定出404个DER。基于六个独立的预后相关lncRNA(包括 , 和 )构建了风险评分系统。确定独立的临床预后因素(病理M、病理T和RS模型状态)后,建立了列线图生存模型。在ceRNA调控网络中,有三个lncRNA、四个miRNA和77个mRNA。此外,PPAR信号通路和刺猬信号通路在ceRNA调控网络中的mRNA中富集。风险评分系统和列线图生存模型可用于预测COAD复发。此外,PPAR信号通路和刺猬信号通路可能影响COAD患者的复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/2a296950a36f/fonc-10-00081-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/3d86ae049bfd/fonc-10-00081-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/ef17b220867a/fonc-10-00081-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/23e12b52b934/fonc-10-00081-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/84936931caed/fonc-10-00081-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/5bd8d8b1de33/fonc-10-00081-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/b3562ef2afb6/fonc-10-00081-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/2a296950a36f/fonc-10-00081-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/3d86ae049bfd/fonc-10-00081-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/ef17b220867a/fonc-10-00081-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/23e12b52b934/fonc-10-00081-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/84936931caed/fonc-10-00081-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/5bd8d8b1de33/fonc-10-00081-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/b3562ef2afb6/fonc-10-00081-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d67/7015976/2a296950a36f/fonc-10-00081-g0007.jpg

相似文献

1
A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.一种基于6个长链非编码RNA的风险评分系统用于预测结肠癌患者的复发情况。
Front Oncol. 2020 Feb 6;10:81. doi: 10.3389/fonc.2020.00081. eCollection 2020.
2
Integrative analysis of ceRNA network reveals functional lncRNAs associated with independent recurrent prognosis in colon adenocarcinoma.ceRNA网络的综合分析揭示了与结肠腺癌独立复发预后相关的功能性长链非编码RNA。
Cancer Cell Int. 2021 Jul 5;21(1):352. doi: 10.1186/s12935-021-02069-6.
3
Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.基于竞争性内源 RNA 的结肠癌复发预后预测模型。
BMC Cancer. 2020 Oct 7;20(1):968. doi: 10.1186/s12885-020-07163-y.
4
A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.基于预后长链非编码 RNA 特征的结肠癌复发的潜在预后预测模型。
Hum Genomics. 2020 Jun 10;14(1):24. doi: 10.1186/s40246-020-00270-8.
5
Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.基于 lncRNA 相关 ceRNA 调控网络的宫颈癌预后相关显著生物标志物筛选及功能研究
Comb Chem High Throughput Screen. 2021;24(3):472-482. doi: 10.2174/1386207323999200729113028.
6
Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.长链非编码 RNA(lncRNA)在结肠腺癌发生中的作用的综合分析。
BMC Med Genomics. 2020 Jul 29;13(1):108. doi: 10.1186/s12920-020-00757-2.
7
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.综合分析 mRNA 和 lncRNA 的差异表达谱,并鉴定出用于结直肠腺癌患者的 14-lncRNA 预后特征。
Oncol Rep. 2018 May;39(5):2365-2375. doi: 10.3892/or.2018.6324. Epub 2018 Mar 19.
8
Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.长链非编码RNA相关的竞争性内源RNA网络分析揭示了人类结肠腺癌中潜在的长链非编码RNA生物标志物。
Cell Physiol Biochem. 2018;49(5):1778-1791. doi: 10.1159/000493623. Epub 2018 Sep 19.
9
Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma.基于ceRNA网络筛选早期肺腺癌关键预后因素并构建生存预后风险预测模型
Transl Cancer Res. 2021 Nov;10(11):4652-4663. doi: 10.21037/tcr-20-3273.
10
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.鉴定长链非编码 RNA 生物标志物,用于诊断和预测结肠腺癌患者的预后。
J Cell Biochem. 2019 Mar;120(3):4121-4131. doi: 10.1002/jcb.27697. Epub 2018 Sep 30.

引用本文的文献

1
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells.长链非编码RNA H19增强ITF2357(一种组蛋白去乙酰化酶抑制剂)在结肠癌细胞中的促凋亡活性。
Front Pharmacol. 2023 Sep 28;14:1275833. doi: 10.3389/fphar.2023.1275833. eCollection 2023.
2
Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma.P4HA3在结肠腺癌中的预后价值及免疫作用
Int J Gen Med. 2023 May 23;16:1953-1971. doi: 10.2147/IJGM.S407068. eCollection 2023.
3
T2DB: A Web Database for Long Non-Coding RNA Genes in Type II Diabetes.

本文引用的文献

1
Development and validation of a five-lncRNA signature with prognostic value in colon cancer.具有结肠癌预后价值的五lncRNA特征的开发与验证
J Cell Biochem. 2020 Aug;121(8-9):3780-3793. doi: 10.1002/jcb.29518. Epub 2019 Nov 3.
2
Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients.综合分析揭示了胃癌患者无病生存的潜在长链非编码RNA生物标志物及其潜在生物学功能。
Cancer Cell Int. 2019 May 7;19:123. doi: 10.1186/s12935-019-0846-6. eCollection 2019.
3
Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492/FOXK1 signaling.
T2DB:一个关于2型糖尿病中长链非编码RNA基因的网络数据库。
Noncoding RNA. 2023 May 8;9(3):30. doi: 10.3390/ncrna9030030.
4
Prognostic Roles of ceRNA Network-Based Signatures in Gastrointestinal Cancers.基于ceRNA网络的特征在胃肠道癌症中的预后作用
Front Oncol. 2022 Jul 18;12:921194. doi: 10.3389/fonc.2022.921194. eCollection 2022.
5
A role of TTI1 in the colorectal cancer by promoting proliferation.TTI1通过促进增殖在结直肠癌中发挥作用。
Transl Cancer Res. 2021 Mar;10(3):1378-1388. doi: 10.21037/tcr-20-3322.
6
A Novel Prognostic Prediction Model for Colorectal Cancer Based on Nine Autophagy-Related Long Noncoding RNAs.一种基于九个自噬相关长链非编码RNA的结直肠癌新型预后预测模型。
Front Oncol. 2021 Oct 8;11:613949. doi: 10.3389/fonc.2021.613949. eCollection 2021.
7
Integrative analysis of ceRNA network reveals functional lncRNAs associated with independent recurrent prognosis in colon adenocarcinoma.ceRNA网络的综合分析揭示了与结肠腺癌独立复发预后相关的功能性长链非编码RNA。
Cancer Cell Int. 2021 Jul 5;21(1):352. doi: 10.1186/s12935-021-02069-6.
8
Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression.干扰 KCNJ2 通过上调 GNG2 表达抑制甲状腺乳头癌细胞的增殖、迁移和 EMT 进展。
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12261. Epub 2021 Jul 2.
9
Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.靶向反义长链非编码RNA PRKAG2-AS1作为一种治疗靶点可抑制肝癌细胞的恶性行为。
Front Med (Lausanne). 2021 Apr 13;8:649279. doi: 10.3389/fmed.2021.649279. eCollection 2021.
10
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer.蛋白质组学分析揭示了优化结肠癌预后预测的特征。
J Cancer. 2021 Feb 22;12(8):2199-2205. doi: 10.7150/jca.50630. eCollection 2021.
长链非编码RNA LINC01503通过调控miR-4492/FOXK1信号通路促进结肠癌细胞的增殖和侵袭。
Exp Ther Med. 2018 Dec;16(6):4879-4885. doi: 10.3892/etm.2018.6775. Epub 2018 Sep 19.
4
Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.长非编码 RNA LINC00899 作为急性髓系白血病诊断和预后预测的新型血清标志物。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7364-7370. doi: 10.26355/eurrev_201811_16274.
5
Colon cancer screening with CT colonography: logistics, cost-effectiveness, efficiency and progress.CT结肠成像用于结肠癌筛查:后勤保障、成本效益、效率及进展
Br J Radiol. 2018 Oct;91(1090):20180307. doi: 10.1259/bjr.20180307. Epub 2018 Jul 5.
6
Tumor location impact in stage II and III colon cancer: epidemiological and outcome evaluation.肿瘤位置对II期和III期结肠癌的影响:流行病学及预后评估
J Gastrointest Oncol. 2018 Apr;9(2):263-268. doi: 10.21037/jgo.2017.12.02.
7
Long noncoding RNA CYTOR in cancer: A TCGA data review.长链非编码 RNA CYTOR 在癌症中的作用:TCGA 数据分析综述
Clin Chim Acta. 2018 Aug;483:227-233. doi: 10.1016/j.cca.2018.05.010. Epub 2018 May 8.
8
A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer.LncRNA-CYTOR 与 Wnt/β-连环蛋白信号之间的正反馈环促进结肠癌转移。
Mol Ther. 2018 May 2;26(5):1287-1298. doi: 10.1016/j.ymthe.2018.02.024. Epub 2018 Mar 6.
9
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.综合分析 mRNA 和 lncRNA 的差异表达谱,并鉴定出用于结直肠腺癌患者的 14-lncRNA 预后特征。
Oncol Rep. 2018 May;39(5):2365-2375. doi: 10.3892/or.2018.6324. Epub 2018 Mar 19.
10
Clinical Trials and Progress in Metastatic Colon Cancer.转移性结肠癌的临床试验与进展
Surg Oncol Clin N Am. 2018 Apr;27(2):349-365. doi: 10.1016/j.soc.2017.11.008.